Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma
暂无分享,去创建一个
K. Yeom | M. Monje | H. Vogel | P. Barnes | Yoon-Jae Cho | M. Edwards | R. Lober | Yujie Tang | P. Fisher | Michelle Monje
[1] K. Yeom,et al. Prognostic role for diffusion-weighted imaging of pediatric optic pathway glioma , 2013, Journal of Neuro-Oncology.
[2] Matthew M. Pearson,et al. Diffusion-Weighted MRI: Distinction of Skull Base Chordoma from Chondrosarcoma , 2013, American Journal of Neuroradiology.
[3] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[4] David T. W. Jones,et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.
[5] David T. W. Jones,et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas , 2012, Acta Neuropathologica.
[6] P. Varlet,et al. Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas , 2012, PloS one.
[7] W. Vandertop,et al. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. , 2012, Cancer treatment reviews.
[8] David T. W. Jones,et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.
[9] Li Ding,et al. Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.
[10] D. Hammoud,et al. Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. , 2011, Neuro-oncology.
[11] J. Shih,et al. Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma , 2011, Journal of Neuro-Oncology.
[12] I. Pollack,et al. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). , 2011, Neuro-oncology.
[13] W. Reddick,et al. Quantitative Diffusion-Weighted and Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Analysis of T2 Hypointense Lesion Components in Pediatric Diffuse Intrinsic Pontine Glioma , 2011, American Journal of Neuroradiology.
[14] E. Gasparetto,et al. Diffusion MR imaging in central nervous system. , 2011, Magnetic resonance imaging clinics of North America.
[15] A. Panigrahy,et al. Apparent Diffusion and Fractional Anisotropy of Diffuse Intrinsic Brain Stem Gliomas , 2010, American Journal of Neuroradiology.
[16] S. Cha,et al. Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System Lymphoma , 2010, American Journal of Neuroradiology.
[17] J. Brandon,et al. Conventional MRI at presentation does not predict clinical response to radiation therapy in children with diffuse pontine glioma , 2009, Pediatric Radiology.
[18] R. McKinstry,et al. Diffusion-weighted and dynamic contrast-enhanced imaging as markers of clinical behavior in children with optic pathway glioma , 2008, Pediatric Radiology.
[19] N. Chuang,et al. Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma , 2008, Journal of Neuro-Oncology.
[20] Daniel L. A. Camacho,et al. Apparent diffusion coefficients for differentiation of cerebellar tumors in children. , 2006, AJNR. American journal of neuroradiology.
[21] S. Donaldson,et al. Advances toward an understanding of brainstem gliomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] D. Hargrave,et al. Diffuse brainstem glioma in children: critical review of clinical trials. , 2006, The Lancet. Oncology.
[23] James M Provenzale,et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. , 2002, Radiology.
[24] R C McKinstry,et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. , 2001, AJR. American journal of roentgenology.
[25] Toshinori Hirai,et al. Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.
[26] T L Chenevert,et al. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] K. Krabbe,et al. MR diffusion imaging of human intracranial tumours , 1997, Neuroradiology.
[28] J G Pipe,et al. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. , 1995, AJNR. American journal of neuroradiology.
[29] R D Tien,et al. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. , 1994, AJR. American journal of roentgenology.
[30] J. Krischer,et al. Brain stem gliomas: a classification system based on magnetic resonance imaging. , 1990, Pediatric neurosurgery.
[31] P. Grenier,et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.
[32] C. Kruchko,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.
[33] M. Prados,et al. Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. , 1996, Pediatric neurosurgery.
[34] J V Hajnal,et al. MR imaging of anisotropically restricted diffusion of water in the nervous system: technical, anatomic, and pathologic considerations. , 1991, Journal of computer assisted tomography.